Active Supportive Care and Symptom Management Grants

PI Namesort descending Organization - Company Title FOA
Abdi, Salahadin University Of Tx Md Anderson Can Ctr Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults with Cancer: A two arm pilot study PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Bao, Ting Sloan-Kettering Inst Can Research Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT)Trial PA-18-141: Mechanisms, Models, Measurement, and Management in Pain Research
Bao, Ting Sloan-Kettering Inst Can Research Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial PA-18-141: Mechanisms, Models, Measurement, and Management in Pain Research
Geisler, Stefanie Washington University Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Gewandter, Jennifer University Of Rochester Wireless transcutaneous electrical stimulation (TENS) for chemotherapy-induced peripheral neuropathy: A phase II randomized clinical trial PA-18-159: Mechanisms, Models, Measurement, and Management in Pain Research
Hu, Shuiying Ohio State University Prevention of paclitaxel-induced peripheral neuropathy with nilotinib RFA-CA-18-019: Research Answers to National Cancer Institute's (NCI) Provocative Questions
Kolb, Noah Allan University Of Vermont & St Agric College Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Kroetz, Deanna L University Of California, San Francisco Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity PA-20-185: NIH Research Project Grant
Levine, Jon David University Of California, San Francisco Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress
Lin, Po-Ju University Of Rochester Assessing the role of the interoceptive brain system in the pathophysiology and treatment of chemotherapy-induced peripheral neuropathy PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Melemedjian, Ohannes Kevork University Of Maryland Baltimore Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy RFA-NS-18-043: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment
Salvemini, Daniela Saint Louis University A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity PAR-16-275: Serious Adverse Drug Reaction Research
Smith, Ellen Mary Lavoie University Of Alabama At Birmingham Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Staff, Nathan P Mayo Clinic Rochester Assessment of Chemotherapy-Induced Peripheral Neuropathy Susceptibility Using Patient-derived iPSC Technology PA-16-160: NIH Research Project Grant
Visovsky, Constance G. University Of South Florida Home-Based Physical Activity Intervention for Taxane-Induced CIPN PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program

Pages